Vanguard Group Inc Vaxart, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,077,418 shares of VXRT stock, worth $5.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,077,418
Previous 9,950,952
1.27%
Holding current value
$5.84 Million
Previous $6.67 Million
28.47%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VXRT
# of Institutions
110Shares Held
37.6MCall Options Held
188KPut Options Held
180K-
Sio Capital Management, LLC New York, NY13.6MShares$7.89 Million6.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.97MShares$2.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.54MShares$1.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$1.03 Million0.0% of portfolio
-
Silverarc Capital Management, LLC1MShares$580,0000.21% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $73.4M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...